HIV-1 maturation inhibitor bevirimat stabilizes the immature gag lattice

Journal of Virology

Volumn 85, Issue 4, 2011, Pages 1420-1428

  Keller, Paul W ^a   Adamson, Catherine S ^b,c   Bernard Heymann, J ^a   Freed, Eric O ^c   Steven, Alasdair C ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVIRIMAT; GAG PROTEIN; MPC 4326; SPACER PEPTIDE 1; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ISOLATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG CONFORMATION; DRUG PROTEIN BINDING; ELECTRON TOMOGRAPHY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN CLEAVAGE; PROTEIN PROCESSING; PROTEIN STABILITY; VIRION; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS MORPHOLOGY; VIRUS MUTANT; VIRUS NUCLEOCAPSID; VIRUS PARTICLE; VIRUS REPLICATION;

ANTI-HIV AGENTS; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENES, GAG; HELA CELLS; HIV-1; HUMANS; MUTATION; SUCCINATES; TOMOGRAPHY; TRITERPENES; VIRION; VIRUS ASSEMBLY;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

EID: 78951488338     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01926-10     Document Type: Article

References (43)

1. Adachi, A., et al. 1986. Production of acquired immunodeficiency syndromeassociated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291. (Pubitemid 16013975)
2. Adamson, C. S., et al. 2006. In vitro resistance to the human immunodefi- ciency virus type 1 maturation inhibitor PA-457 (bevirimat). J. Virol. 80: 10957-10971.
3. Adamson, C. S., and E. O. Freed. 2007. Human immunodeficiency virus type 1 assembly, release, and maturation. Adv. Pharmacol. 55:347-387.
4. Adamson, C. S., and E. O. Freed. 2008. Recent progress in antiretrovirals- lessons from resistance. Drug Discov. Today 13:424-432.
5. Adamson, C. S., M. Sakalian, K. Salzwedel, and E. O. Freed. 2010. Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV-1 maturation inhibitor bevirimat. Retrovirology 7:36.
6. Adamson, C. S., K. Salzwedel, and E. O. Freed. 2009. Virus maturation as a new HIV-1 therapeutic target. Expert Opin. Ther. Targets 13:895-908.
7. Adamson, C. S., K. Waki, S. D. Ablan, K. Salzwedel, and E. O. Freed. 2009. Impact of human immunodeficiency virus type 1 resistance to protease inhibitors on evolution of resistance to the maturation inhibitor bevirimat (PA-457). J. Virol. 83:4884-4894.
8. Aiken, C., and C. H. Chen. 2005. Betulinic acid derivatives as HIV-1 antivirals. Trends Mol. Med. 11:31-36.
9. Benjamin, J., B. K. Ganser-Pornillos, W. F. Tivol, W. I. Sundquist, and G. J. Jensen. 2005. Three-dimensional structure of HIV-1 virus-like particles by electron cryotomography. J. Mol. Biol. 346:577-588.
10. Briggs, J. A., et al. 2006. The mechanism of HIV-1 core assembly: insights from three-dimensional reconstructions of authentic virions. Structure 14: 15-20.
11. Briggs, J. A., et al. 2009. Structure and assembly of immature HIV. Proc. Natl. Acad. Sci. U. S. A. 106:11090-11095.
12. Briggs, J. A., et al. 2004. The stoichiometry of Gag protein in HIV-1. Nat. Struct. Mol. Biol. 11:672-675.
13. Briggs, J. A., T. Wilk, R. Welker, H. G. Kräusslich, and S. D. Fuller. 2003. Structural organization of authentic, mature HIV-1 virions and cores. EMBO J. 22:1707-1715.
14. Butan, C., D. C. Winkler, J. B. Heymann, R. C. Craven, and A. C. Steven. 2008. RSV capsid polymorphism correlates with polymerization efficiency and envelope glycoprotein content: implications that nucleation controls morphogenesis. J. Mol. Biol. 376:1168-1181.
15. Campos-Olivas, R., J. L. Newman, and M. F. Summers. 2000. Solution structure and dynamics of the Rous sarcoma virus capsid protein and comparison with capsid proteins of other retroviruses. J. Mol. Biol. 296:633-649.
16. Cardone, G., K. Grünewald, and A. C. Steven. 2005. A resolution criterion for electron tomography based on cross-validation. J. Struct. Biol. 151:117-129.
17. Cardone, G., J. G. Purdy, N. Cheng, R. C. Craven, and A. C. Steven. 2009. Visualization of a missing link in retrovirus capsid assembly. Nature 457: 694-698.
18. Carlson, L. A., et al. 2008. Three-dimensional analysis of budding sites and released virus suggests a revised model for HIV-1 morphogenesis. Cell Host Microbe 4:592-599.
19. Checkley, M. A., B. G. Luttge, F. Soheilian, K. Nagashima, and E. O. Freed. 2010. The capsid-spacer peptide 1 Gag processing intermediate is a dominant- negative inhibitor of HIV-1 maturation. Virology 400:137-144.
20. Dafonseca, S., et al. 2008. The inhibition of assembly of HIV-1 virus-like particles by 3-O-(3′,3′-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its zinc-binding domain. Virol. J. 5:162.
21. Demirov, D. G., and E. O. Freed. 2004. Retrovirus budding. Virus Res. 106:87-102.
22. Frangakis, A. S., et al. 2002. Identification of macromolecular complexes in cryoelectron tomograms of phantom cells. Proc. Natl. Acad. Sci. U. S. A. 99:14153-14158.
23. Frangakis, A. S., and R. Hegerl. 2001. Noise reduction in electron tomographic reconstructions using nonlinear anisotropic diffusion. J. Struct. Biol. 135:239-250.
24. Frank, J. 2006. Electron tomography, 2nd ed. Springer, New York, NY.
25. Freed, E. O., and M. A. Martin. 1994. Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120. J. Virol. 68:2503-2512.
26. Freed, E. O., J. M. Orenstein, A. J. Buckler-White, and M. A. Martin. 1994. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J. Virol. 68:5311-5320.
27. Fujioka, T., et al. 1994. Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids. J. Nat. Prod. 57:243-247.
28. Gamble, T. R., et al. 1997. Structure of the carboxy-terminal dimerization domain of the HIV-1 capsid protein. Science 278:849-853.
29. Ganser-Pornillos, B. K., A. Cheng, and M. Yeager. 2007. Structure of fulllength HIV-1 CA: a model for the mature capsid lattice. Cell 131:70-79.
30. Harris, A., et al. 2006. Influenza virus pleiomorphy characterized by cryoelectron tomography. Proc. Natl. Acad. Sci. U. S. A. 103:19123-19127.
31. Heymann, J. B., C. Butan, D. C. Winkler, R. C. Craven, and A. C. Steven. 2008. Irregular and semi-regular polyhedral models for Rous sarcoma virus cores. Comput. Math. Methods Med. 9:197-210.
32. Heymann, J. B., G. Cardone, D. C. Winkler, and A. C. Steven. 2008. Computational resources for cryo-electron tomography in Bsoft. J. Struct. Biol. 161:232-242.
33. Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 69:6810-6818.
34. Jin, Z., L. Jin, D. L. Peterson, and C. L. Lawson. 1999. Model for lentivirus capsid core assembly based on crystal dimers of EIAV p26. J. Mol. Biol. 286:83-93.
35. Khorasanizadeh, S., R. Campos-Olivas, and M. F. Summers. 1999. Solution structure of the capsid protein from the human T-cell leukemia virus type-I. J. Mol. Biol. 291:491-505.
36. Lanman, J., et al. 2004. Key interactions in HIV-1 maturation identified by hydrogen-deuterium exchange. Nat. Struct. Mol. Biol. 11:676-677.
37. Li, F., et al. 2003. PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing. Proc. Natl. Acad. Sci. U. S. A. 100:13555-13560.
38. Li, F., et al. 2006. Determinants of activity of the HIV-1 maturation inhibitor PA-457. Virology 356:217-224.
39. Li, S., C. P. Hill, W. I. Sundquist, and J. T. Finch. 2000. Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature 407:409-413.
40. Mastronarde, D. N. 2005. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152:36-51.
41. Mortuza, G. B., et al. 2008. Structure of B-MLV capsid amino-terminal domain reveals key features of viral tropism, Gag assembly and core formation. J. Mol. Biol. 376:1493-1508.
42. Mortuza, G. B., et al. 2004. High-resolution structure of a retroviral capsid hexameric amino-terminal domain. Nature 431:481-485.
43. Ono, A., A. A. Waheed, A. Joshi, and E. O. Freed. 2005. Association of human immunodeficiency virus type 1 Gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel Gag multimerization assay. J. Virol. 79:14131-14140.